bluebird bio (NASDAQ: BLUE)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of bluebird bio (NASDAQ: BLUE) through any online brokerage.
The latest price target for bluebird bio (NASDAQ: BLUE) was reported by Goldman Sachs on Tuesday, May 24, 2022. The analyst firm set a price target for 2.00 expecting BLUE to fall to within 12 months (a possible -53.38% downside). 19 analyst firms have reported ratings in the last year.
The stock price for bluebird bio (NASDAQ: BLUE) is $4.29 last updated June 27, 2022, 8:00 PM UTC.
There are no upcoming dividends for bluebird bio.
bluebird bio’s Q2 earnings are confirmed for Monday, August 8, 2022.
There is no upcoming split for bluebird bio.
bluebird bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.